APVO vs ECL · rev $3.1M vs P/E 35, rev $4.01B
Aptevo Therapeutics Inc (APVO) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
APVO currently screens at market cap $9.9M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the APVO and ECL stock pages for the full models.
Not investment advice.